Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Prevest Denpro Ltd (543363)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543363 NSE: Medical Equipment/Supplies/Accessories | Small Cap | Prevest Denpro Share Price
₹382.85 2.80 (0.74%)
As on 28-Sep'26 16:59
Prevest Denpro Ltd (543363)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543363 NSE: Medical Equipment/Supplies/Accessories | Small Cap | Prevest Denpro Share Price
₹382.85 2.80 (0.74%)
As on 28-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹456 Cr.
Current Price
₹382.9
52-Week Low / High
₹318 / 560
TTM EPS
₹18.1
TTM Sales
₹75.1 Cr.
Book Value per Share
₹108.7
P/E Ratio
21.00
Lower than its 5-year historical median
Industry PE
127.6
Price to Book (P/B)
3.50
Lower than its 5-year historical median
Price to Sales (P/S)
6.07
Lower than its 5-year historical median
EV/EBITDA
12.28
Lower than its 5-year historical median
Dividend Yield
0.26%
Profitability Efficiency
Return on Equity (ROE)
17.79%
In line with industry median
Return on Capital Employed (ROCE)
24.21%
Outperforms industry median
Return on Assets (ROA)
16.68%
Operating Profit Margin
34.8%
Net Profit Margin
28.53%
Gross Profit Margin
40.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
13.62%
Operating Profit Growth (1 Year)
-
11.82%
Net Profit Growth (1 Year)
-
12.83%
Asset Quality
Promoter Holding
73.60%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹118 Cr.
Equity
₹12 Cr.
Face Value
₹10
All Time Low / High
₹170.65 / 686.00
Check Before You Invest
Quality
Somewhat GoodValuation
UndervaluedCheck Valuation charts
Price Trend
Weak
Is Prevest Denpro Ltd a good quality company?
Prevest Denpro Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Prevest Denpro Ltd performance compare with that of its Peers?
Revenue growth of Prevest Denpro Ltd vs industry peers?
Prevest Denpro Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Prevest Denpro Ltd?
Promoters hold 73.60% of the Prevest Denpro Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Prevest Denpro Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 13.45% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Prevest Denpro Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 37.2% | 39.3% | 45.6% | 47% | 39.6% | 32.3% | 26.8% | 25.3% | 24.9% | - |
| Value Creation Index ⓘ | NA | 1.7 | 1.8 | 2.3 | 2.4 | 1.8 | 1.3 | 0.9 | 0.8 | 0.8 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 17 | 19.3 | 22.8 | 28.5 | 38.1 | 49.9 | 56.4 | 63.1 | 71.7 | 75 |
| Sales YoY Gr. | - | NA | 13.6% | 18.1% | 25.1% | 33.8% | 30.8% | 13.2% | 11.8% | 13.6% | - |
| Adj EPS ⓘ | 0 | 2.4 | 3.3 | 5.6 | 8 | 9.5 | 12.9 | 13.2 | 15 | 17.6 | 18.8 |
| YoY Gr. | - | NA | 39.5% | 68.4% | 43.1% | 18.3% | 35.8% | 3% | 13.1% | 17.2% | - |
| BVPS (₹) ⓘ | 0 | 8.3 | 11.7 | 17.3 | 25.5 | 47.6 | 60.7 | 73.8 | 88 | 104.8 | 109.6 |
| Adj Net Profit ⓘ | 0 | 2.1 | 2.9 | 4.9 | 7.1 | 11.4 | 15.4 | 15.9 | 18 | 21.1 | 23 |
| Cash Flow from Ops. ⓘ | 0 | 2.4 | 3 | 4.7 | 8.8 | 7 | 10.4 | 11.5 | 15 | 15.9 | - |
| Debt/CF from Ops. ⓘ | 0 | 0.5 | 0.5 | 0.4 | 0.2 | 0.2 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 20.3% | 12.9% | 13.6% | ||||
| Adj EPS ⓘ | NA | 17% | 11% | 17.2% | ||||
| BVPSⓘ | NA | 32.7% | 20% | 19.2% | ||||
| Share Price | - | 14% | -5% | -30.4% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 28.8 | 33.3 | 38.6 | 37.4 | 28.6 | 23.8 | 19.7 | 18.5 | 18.2 | 17.5 |
| Op. Profit Mgn % ⓘ | 0 | 18 | 20.1 | 22.8 | 31.7 | 39.9 | 39.7 | 35.5 | 35.4 | 36 | 35.7 |
| Net Profit Mgn % ⓘ | 0 | 12.4 | 15.2 | 21.7 | 24.8 | 29.8 | 31 | 28.2 | 28.5 | 29.4 | 29.9 |
| Debt to Equity ⓘ | 0 | 0.2 | 0.1 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 0 | 69 | 74 | 75 | 76 | 85 | 100 | 107 | 114 | 242 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 14 | 19 | -4 | -2 | 32 | 58 | 70 | 69 | 226 |
Valuation of Prevest Denpro - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|
| Sales | 56 | 63 | 72 |
| Operating Expenses ⓘ + | 36 | 41 | 47 |
| Operating Profit ⓘ | 20 | 22 | 25 |
| Operating Profit Margin (%) | 35.5% | 35.4% | 34.8% |
| Other Income ⓘ + | 3 | 4 | 5 |
| Interest ⓘ | 0 | 0 | 0 |
| Depreciation ⓘ | 1 | 2 | 2 |
| Profit Before Tax ⓘ | 21 | 24 | 28 |
| Tax ⓘ | 5 | 6 | 7 |
| Profit After Tax | 16 | 18 | 20 |
| PAT Margin (%) | 28.6% | 28.8% | 28.5% |
| Adjusted EPS (₹) | 13.4 | 15.1 | 17.1 |
| Dividend Payout Ratio (%) | 7.40% | 6.60% | 5.90% |
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 89 | 106 | 125 | ||||||||
| Debt + | 0 | 0 | 0 | ||||||||
| Minority Interest | 0 | 0 | 0 | ||||||||
| Trade Payables | 1 | 2 | 2 | ||||||||
| Others Liabilities ⓘ | 5 | 5 | 6 | ||||||||
| Total Liabilities ⓘ | 95 | 113 | 133 | ||||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 27 | 27 | 27 | ||||||||
| CWIP ⓘ | 0 | 0 | 0 | ||||||||
| Investments ⓘ | 2 | 5 | 9 | ||||||||
| Inventories | 6 | 8 | 11 | ||||||||
| Trade Receivables | 8 | 8 | 9 | ||||||||
Cash Equivalents 
ⓘ
| 49 | 61 | 73 | ||||||||
| Others Assets ⓘ | 3 | 4 | 5 | ||||||||
| Total Assets ⓘ | 95 | 113 | 133 | ||||||||
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 12 | 15 | 15 |
| Cash Flow From Investing Activity ⓘ + | -2 | -1 | -2 |
| Cash Flow From Financing Activity ⓘ + | -0 | -1 | -1 |
| Net Cash Flow ⓘ | 10 | 12 | 12 |
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 18.21 | 18.7 | 17.79 | |||||||
| ROCE (%) | 24.42 | 25.24 | 24.21 | |||||||
| Asset Turnover Ratio | 0.62 | 0.63 | 0.6 | |||||||
| PAT to CFO Conversion(x) | 0.75 | 0.83 | 0.75 | |||||||
| Working Capital Days | ||||||||||
| Receivable Days | 50.70 | 44.40 | 40.50 | |||||||
| Inventory Days | 38.90 | 40.10 | 46.70 | |||||||
| Payable Days | 32.10 | 41.90 | 45.20 | |||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Prevest Denpro Ltd FAQs
The current trading price of Prevest Denpro on 28-Sep-2026 16:59 is ₹382.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of Prevest Denpro stood at ₹456.2 Cr
The latest P/E ratio of Prevest Denpro as of 27-Sep-2026 is 20.21.
The latest P/B ratio of Prevest Denpro as of 27-Sep-2026 is 3.47.
The 52-week high of Prevest Denpro is ₹559.9 and the 52-week low is ₹318.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Prevest Denpro is ₹75.39 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Prevest Denpro Ltd is a average quality company.
The key valuation ratios of Prevest Denpro Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Prevest Denpro Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Prevest Denpro Ltd
The company develops, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The breadth and depth of its product offerings address majority of the dentists’ clinical needs for consumable dental materials. Its product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables. Its products are sold in the regions of Europe, Asia, South America, Middle East and Africa. Further, as per its diversification plans, the company is currently expanding its existing manufacturing unit by setting up another manufacturing facility for manufacturing new line of products that will include hygiene products (sanitizers and disinfectants), oral hygiene products (mouth washes and mouth rinses), oral care products(medicated ointments, gels and creams for dental treatment) and biomaterials (i.e. bone augmentation materials). The proposed facility will be well-equipped with latest machineries.
Business area of the company
The company manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.
Key events and milestones
- 1999: Incorporation of the Company.
- 2000: First Manufacturing unit was established at Digiana, Jammu, J&K.
- 2011: Second Manufacturing unit was established at Samba, J&K.
- 2014-15: Crossed Turnover of Rs 10 crore.
- 2016: Won Sushruta award for Best Dental Manufacture by the Indian Dental Association’s.
- 2016: Received Certificate for ‘Best Enterprise’ in the field of manufacture of dental materials, India by the Socrates Committee, Oxford, UK.
- 2017: Shifted manufacturing operations from First Manufacturing Unit to Second Manufacturing unit.
- 2017: Won “Northern Region Export Excellence Award” - Gold Trophy for outstanding export performance in the category of top exporter J&K - SME by FIEO (2017).
- 2019-20: Crossed Turnover of Rs 20 crore.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
